BRCA2 and ovarian carcinoma: Another prominent result that showed up in both the EUR and non-EUR groups was between BRCA2 and ovarian cancer (EUR: p = 1.6 × 10−8, OR = 13; non-EUR: p = 1.0 × 10−5, OR = 33).